推进循环肿瘤细胞和肺癌的发展
摘要
肺癌仍然是世界上最致命的肿瘤。每年有超过100万人因此病丧生[1]。（肺）癌最常见的死因是转移癌。肿瘤细胞在起病部位之外的组织中传播和生长，肿瘤负荷迅速增加[2]。非小细胞肺癌（non—small cell lung carcinoma，NSCLC）约占所有肺癌病例的85％，并且是全球癌症相关死亡的首要原因。约70％的患者在就诊时已达疾病晚期，
出处
《国际病理科学与临床杂志》
CAS
2013年第5期374-375,共2页
Journal of International Pathology and Clinical Medicine
作者简介
通信作者：T．JeroenN．Hiltermann，博士，主要从事肺部疾病尤其是肺癌的基因学研究。Email：t4．n．hiltermann@umcg．nl
参考文献16
-
1Anon. Moving cancer up the global health agenda[J]. Lancet, 2010, 375(9731): 2051.
-
2Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization[J]. Nat Rev Cancer, 2009, 9( 4): 274-284.
-
3Mountain CF. The international system for staging lung cancer[J]. Semin Surg Oncol, 2000,18(2): 106-115.
-
4anku F, Garrido-Laguna I, Petruzelka LB, et al, Novel therapeutic targets in non-small cell lung cancer[J).] Thorac Oncol, 2011, 6(9): 1601-1612.
-
5Mok TS, Wu YL, Thongprasert S, et aJ. Gefitinib or carboplatin?paclitaxel in pulmonary adenocarcinoma[J). N Engl] Med, 2009, 361(10): 947-957.
-
6Sequist LV, Waltman BA, Dias-Santagata D, et aJ. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors[J]. Sci Transl Med, 2011, 3(75): 7Sra26.
-
7Shaw AT, Yeap BY, Solomon B], et al. Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis[J]. Lancet Oncol, 2011,12(11): 1004-1012.
-
8Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells[J]. Nat Rev Cancer, 2008, 8(5): 329-340.
-
9Budd GT, Cristofanilli M, Ellis M], et a1. Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer[J). Clin Cancer Res, 2006,12(21): 6403-6409.
-
10Cohen S], Punt C], Iannotti N, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer[J].] Clin Oncol, 2008, 26(19): 3213-3221.
-
1李雷,沈雄虎.回盲部非霍奇金淋巴瘤:病例报告并文献复习[J].科学中国人,2017(1Z).
-
2余谦,刘汉锋.1371例淋巴瘤临床特点及临床病理分析[J].内科,2011,6(2):104-107. 被引量：7
-
3杨小芸,龙庭凤,沈丽达,李蓉.霍奇金淋巴瘤143例的临床诊疗[J].昆明医科大学学报,2016,37(6):117-122. 被引量：3
-
4王艳丽,马少林,高英杰.深部热疗联合化疗治疗非小细胞肺癌的疗效分析[J].中国美容医学,2012,21(12X):304-305. 被引量：2
-
5刘平.非小细胞肺癌中DPC4基因的表达及意义[J].青岛医药卫生,2006,38(3):164-165.
-
6王成,董迪.组织学类型对晚期非小细胞肺癌治疗决策的影响[J].癌症进展,2011,9(5):539-541.
-
7李莉,任杰林,张黎,熊永炎.非小细胞肺癌中凋亡相关蛋白与伴神经内分泌分化表达的相关性[J].临床与实验病理学杂志,2008,24(3):273-275.
-
8韩晓黎,江涛.Survivin、P16^(INK4a)在非小细胞肺癌中的表达及意义[J].重庆医科大学学报,2007,32(3):264-267. 被引量：3
-
9尉继伟,石柱.热疗联合化疗与单纯化疗治疗非小细胞肺癌的疗效比较[J].中国微创外科杂志,2007,7(6):538-540. 被引量：2
-
10张婧,黄建国.XELOX方案与SOX方案治疗晚期胃癌的近期疗效比较[J].实用医学杂志,2013,29(1):162-163. 被引量：6
